Work

Real-world outcomes of venetoclax plus hypomethylating agents in BPDCN across treatment lines

Year: 2026

Type: article

Abstract: Not available.

Source: Haematologica

DOI: 10.3324/haematol.2026.301363

Authors: Erica N. Lamkin, Shai Shimony, Shefali Mehra, Andrew Lane, Justin Taylor

Institutions: University of Miami, Sylvester Comprehensive Cancer Center, Dana-Farber Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $2,157

Funders: Florida Department of Health, Edward P. Evans Foundation, Sylvester Comprehensive Cancer Center, University of Miami Health Systems, National Institutes of Health, National Cancer Institute, National Institute of General Medical Sciences

Awards: G3918619244, G5149665659, G6978208827, G752229251, Understanding mechanisms of BTK inhibitor and degrader resistance in patients with chronic lymphocytic leukemia, The role of XPO1 in nuclear export of RNA

OpenAlex ID: W7204468266

FWCI:

Cites:

Cited by:

Related to: